1. Home
  2. TGLS vs ANIP Comparison

TGLS vs ANIP Comparison

Compare TGLS & ANIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tecnoglass Inc.

TGLS

Tecnoglass Inc.

HOLD

Current Price

$42.98

Market Cap

1.9B

ML Signal

HOLD

ANIP

ANI Pharmaceuticals Inc.

HOLD

Current Price

$86.13

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TGLS
ANIP
Founded
1984
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Electronic Components
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
1.8B
IPO Year
2011
1999

Fundamental Metrics

Financial Performance
Metric
TGLS
ANIP
Price
$42.98
$86.13
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
5
Target Price
$63.33
$110.00
AVG Volume (30 Days)
269.5K
293.5K
Earning Date
05-07-2026
05-08-2026
Dividend Yield
1.41%
N/A
EPS Growth
N/A
419.23
EPS
0.71
1.28
Revenue
$370,984,000.00
$206,547,000.00
Revenue This Year
$13.56
$21.01
Revenue Next Year
$9.04
$17.59
P/E Ratio
$60.92
$67.18
Revenue Growth
17.98
2.47
52 Week Low
$37.52
$62.61
52 Week High
$83.32
$99.50

Technical Indicators

Market Signals
Indicator
TGLS
ANIP
Relative Strength Index (RSI) 45.54 61.80
Support Level $40.57 $77.16
Resistance Level $46.65 $87.42
Average True Range (ATR) 1.90 2.60
MACD -0.19 0.34
Stochastic Oscillator 9.43 86.39

Price Performance

Historical Comparison
TGLS
ANIP

About TGLS Tecnoglass Inc.

Tecnoglass Inc is a manufacturer of hi-spec architectural glass and windows for residential and commercial construction industries, operating through its direct and indirect subsidiaries. Its product offerings include tempered glass, laminated glass, thermo-acoustic glass, sliding windows, projecting windows, guillotine windows, sliding doors, loating facades, automatic doors, bathroom dividers, and commercial display windows, among others. The company has one operating segment, Architectural Glass and Windows, which is also its reporting segment. Geographically, the company generates maximum revenue from its customers in the United States, followed by Colombia, Panama, and other regions.

About ANIP ANI Pharmaceuticals Inc.

ANI Pharmaceuticals Inc is a diversified biopharmaceutical company. It is focused on developing, manufacturing, and commercializing therapeutics through its Rare Disease business, which markets novel products in the areas of ophthalmology, rheumatology, nephrology, neurology, and pulmonology; and through its Generics and Brands businesses. The firm's product portfolio comprises Purified Cortrophin Gel, ILUVIEN, and YUTIQ (fluocinolone acetonide intravitreal implant), among others. Additionally, its Generics portfolio includes several products with a wide variety of indications. The company has two operating segments: Rare Disease and Brands, which derive maximum revenue, and Generics and Other. Geographically, it generates maximum revenue from the United States, followed by other markets.

Share on Social Networks: